http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011138477-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44 |
| filingDate | 2010-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011138477-A |
| titleOfInvention | CHINOXALINE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF BENEFIT AND MALIGNANT TUMOR DISEASES |
| abstract | 1. Quinoxaline derivatives of the general formula I: in which X is: oxygen or sulfur; R is: (i) hydrogen, (ii) unsubstituted or substituted (CC) -alkyl, (iii) cyano, (iv) halogen, R / R are itself: (i) hydrogen, (ii) unsubstituted or substituted (CC) -alkyl, R represents: (i) hydrogen, (ii) unsubstituted or substituted (CC) -alkyl, (iii) unsubstituted or substituted cycloalkyl, (iv) unsubstituted or substituted heterocyclyl, (v) unsubstituted or substituted aryl, (vi) unsubstituted or substituted heteroaryl, (vii) unsubstituted or substituted alkylaryl, (viii) n substituted or substituted alkyl heteroaryl, and R-R are: (i) hydrogen, (ii) unsubstituted or substituted (CC) -alkyl, (iii) unsubstituted or substituted aryl, (iv) unsubstituted or substituted heteroaryl, (v) halogen, (vi ) cyano, (vii) hydroxyl, (viii) (CC) alkoxy, (ix) amino, (x) carboxyl, alkoxycarbonyl, carboxyalkyl or alkoxycarbonylalkyl, (xi) alkoxycarbonylamino, alkoxycarbonylaminoalkyl, and provided that at least one of the substituents R -R is an unsubstituted or substituted aryl or heteroaryl radical, and in which the substituents selected from the group consisting of F, Cl, Br, I, CN, CF, NH, NH-alkyl, NH-aryl, N (alkyl), NH-CO-alkyl, NH-CO-aryl, NH-CO-heteroaryl , NH-SO-alkyl, NH-SO-aryl, NH-SO-heteroaryl, NH-CO-NH-alkyl, NH-CO-NH-aryl, NH-CO-NH-heteroaryl, NH-C (O) O -alkyl, NH-C (O) O-aryl, NH-C (O) O-heteroaryl, NO, SH, S-alkyl, OH, OCF, O-alkyl, O-aryl, O-CO-alkyl, O -CO-aryl, O-CO-heteroaryl, O-C (O) O-alkyl, O-C (O) O-aryl, O-C (O) O-heteroaryl, O-CO-NH-alkyl, O -CO-N (alkyl), O-CO-NH-aryl, O-CO-NH-heteroaryl, OSOH, OSO-alkyl, OSO-aryl, OSO-heteroaryl, OP (O) (OH), alkyl-P ( O) (OH) CHO, COH, C (O) O-alkyl, C (O) O-aryl, C (O) O-heteroaryl, CO-alkyl, CO-aryl, CO-heteroaryl, SOH, SO-NH SO-NH- |
| priorityDate | 2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 437.